Notably, α-HB subtype 2 exhibited significant enrichment in various immune and inflammatory pathways, including regulation of response to tumor cells, synaptic vesicle localization, and multiple interleukin-mediated signaling pathways (such as IL-6, IL-4, IL-2, and IL-15). The gene discussed is IL15; the disease is neoplasm.